Company intelligence / Profile preview

Catalyst OrthoScience

Naples, Florida, United Statescatalystortho.com ↗

Ownership: Private
Development stage: Commercial

Overview

Catalyst OrthoScience’s flagship product line—the Archer CSR Total Shoulder System—has demonstrated significant functional improvement and pain reduction for patients undergoing anatomic total shoulder arthroplasty. Mid-term clinical data (5–8 years) show high patient satisfaction, little to no pain post-surgery, significant functional improvements across a wide age range of patients, and very low revision rates that exceed average published data for similar implants. The system preserves more bone than traditional systems and enables less invasive procedures with faster recovery times[6].

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

RC CapitalMutual Capital PartnersBridge Bank

Beyond the preview

Go deeper on Catalyst OrthoScience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catalyst OrthoScience.

Explore the full profile